SUPN
Supernus Pharmaceuticals Inc
Price:  
26.56 
USD
Volume:  
439,915.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN WACC - Weighted Average Cost of Capital

The WACC of Supernus Pharmaceuticals Inc (SUPN) is 8.2%.

The Cost of Equity of Supernus Pharmaceuticals Inc (SUPN) is 8.75%.
The Cost of Debt of Supernus Pharmaceuticals Inc (SUPN) is 10.35%.

Range Selected
Cost of equity 7.40% - 10.10% 8.75%
Tax rate 24.20% - 25.70% 24.95%
Cost of debt 4.00% - 16.70% 10.35%
WACC 5.2% - 11.3% 8.2%
WACC

SUPN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.77 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.10%
Tax rate 24.20% 25.70%
Debt/Equity ratio 1 1
Cost of debt 4.00% 16.70%
After-tax WACC 5.2% 11.3%
Selected WACC 8.2%